you are here: HomeNewsCoronavirus
coronavirus

The new coronavirus strain, first discovered in the central city of Wuhan, has caused alarm because of its connection to Severe Acute Respiratory Syndrome (SARS), which killed nearly 650 people across mainland China and Hong Kong in 2002-2003. More

Jump to
15879 Results Found
  • Business Insight | Moderna to charge $25-$37 per dose for its COVID-19 vaccine Nov 23, 2020 05:03 PM IST

    Business Insight | Moderna to charge $25-$37 per dose for its COVID-19 vaccine

    Moderna’s CEO has said the company will charge governments $25 and $37 per dose for its COVID-19 vaccine

  • AstraZeneca will have 200 million COVID-19 vaccine doses by year-end Nov 23, 2020 04:41 PM IST

    AstraZeneca will have 200 million COVID-19 vaccine doses by year-end

    Pam Cheng said there would be enough vaccine for 20 million doses in Britain by the end of the year, with enough "active" drug substance for 70 million doses for the UK by the end of Q1 2021.

  • Delhiites shift wedding venues to Noida, Gurugram after Delhi restricts number of guests to 50 Nov 23, 2020 03:44 PM IST

    Delhiites shift wedding venues to Noida, Gurugram after Delhi restricts number of guests to 50

    Uncertainty over COVID-19 related guidelines is making people choose neighbouring areas over Delhi, say wedding planners

  • Karnataka COVID-19 panel against reopening schools in December Nov 23, 2020 02:55 PM IST

    Karnataka COVID-19 panel against reopening schools in December

    It was important to consolidate gains made after great efforts in the last eight months to contain the disease in the state, the panel said, pointing to the spike or resurgence of cases in Delhi, Haryana, Gujarat, Rajasthan and others.

  • Tata Group, Singapore Airlines infuse Rs 585 crore in Vistara: Report Nov 23, 2020 02:40 PM IST

    Tata Group, Singapore Airlines infuse Rs 585 crore in Vistara: Report

    The infusion is for maintaining liquidity, covering fixed costs and making payments to lesser,

  • Study shows Favipiravir provides multiple benefits in COVID-19 treatment: Glenmark Pharmaceuticals Nov 23, 2020 02:17 PM IST

    Study shows Favipiravir provides multiple benefits in COVID-19 treatment: Glenmark Pharmaceuticals

    Favipiravir is an antiviral medication that works by inhibiting a viral enzyme called RdRP (RNA dependent RNA polymerase), thereby halting the virus’s replication cycle. This helps control the multiplication of the virus and prevents its spread in the patient, Glenmark said.

  • Bill Gates, the virus and the quest to vaccinate the world Nov 23, 2020 01:55 PM IST

    Bill Gates, the virus and the quest to vaccinate the world

    If the initiative, aided by Bill Gates’ fortune and focus, manages to help protect the world’s poor from a virus that has already killed more than 1.3 million people, it will affirm the strategies he has promoted in his philanthropic work.

  • UP's COVID management has been acknowledged globally: Yogi Adityanath Nov 23, 2020 01:52 PM IST

    UP's COVID management has been acknowledged globally: Yogi Adityanath

    Because of the contribution of those involved in dealing with the pandemic, international organisations like the WHO have praised the coronavirus management of Uttar Pradesh, he said, after digitally inaugurating BSL laboratories in government and private medical colleges and other facilities here.

  • PM Modi meeting with states on November 24: COVID vaccine distribution, plan to curb virus spread likely on agenda Nov 23, 2020 01:45 PM IST

    PM Modi meeting with states on November 24: COVID vaccine distribution, plan to curb virus spread likely on agenda

    PM Narendra Modi is likely to hold multiple meetings – including one with with chief ministers or representatives of states reporting highest number of daily COVID-19 cases.

  • Coronavirus vaccine: Oxford, AstraZeneca say their candidate prevents average 70% people from getting COVID Nov 23, 2020 01:12 PM IST

    Coronavirus vaccine: Oxford, AstraZeneca say their candidate prevents average 70% people from getting COVID

    In India, Serum Institute of India (SII) is conducting clinical trials of the Oxford-AstraZeneca vaccine against COVID-19.

  • MMR vaccine may protect against COVID-19, says study Nov 23, 2020 12:45 PM IST

    MMR vaccine may protect against COVID-19, says study

    The MMR vaccine has been theorised to provide protection against COVID-19, and now the study, published in the journal mBio, provides further proof of this by showing that mumps IgG titers, or levels of IgG antibody, are inversely correlated with severity in recovered COVID-19 patients previously vaccinated with the MMR II vaccine.

  • Coronavirus vaccine India update | Govt to set up air freight stations for distribution: Report Nov 23, 2020 12:42 PM IST

    Coronavirus vaccine India update | Govt to set up air freight stations for distribution: Report

    As some COVID-19 vaccine candidates enter the last stage of human trials, the central government is preparing plans for transportation and distribution.

  • SC says COVID-19 situation has worsened in Delhi, Gujarat, asks Centre, states to file status reports Nov 23, 2020 11:55 AM IST

    SC says COVID-19 situation has worsened in Delhi, Gujarat, asks Centre, states to file status reports

    The bench, also comprising Justices R S Reddy and M R Shah, said that all efforts shall be made by the Centre and the states to mitigate the situation and to deal with the rising number of COVID-19 cases.

  • Coronavirus vaccine update: US likely to get COVID-19 vaccine by mid-December -- when can India expect it? Nov 23, 2020 11:24 AM IST

    Coronavirus vaccine update: US likely to get COVID-19 vaccine by mid-December -- when can India expect it?

    Currently, five coronavirus vaccine candidates are under different phases of clinical trials in India.

  • Another Maharashtra lockdown? This is what CM Uddhav Thackeray, Deputy CM Ajit Pawar say Nov 23, 2020 10:59 AM IST

    Another Maharashtra lockdown? This is what CM Uddhav Thackeray, Deputy CM Ajit Pawar say

    Maharashtra CM Uddhav Thackeray also warned that the second wave of COVID-19 could hit the state "like a tsunami" if people fail to follow safety guidelines.

  • Coronavirus Daily Update: Over 44,000 cases, 511 deaths - India's COVID-19 cases explained in charts Nov 23, 2020 10:45 AM IST

    Coronavirus Daily Update: Over 44,000 cases, 511 deaths - India's COVID-19 cases explained in charts

    India reported over 44,000 new cases according to official update, on November 23, continuing the streak for the 16th consecutive day of registering less than 50,000 new cases of novel coronavirus. Active cases in India continue below the 4.5 lakh mark, however reported a rise--of 2,524 cases.

  • Uttarakhand governor Baby Rani Maurya tests positive for COVID-19 Nov 23, 2020 10:19 AM IST

    Uttarakhand governor Baby Rani Maurya tests positive for COVID-19

    In a tweet on Sunday evening, Maurya said, "My corona report has come out positive. I am asymptomatic and have no problems. I have isolated myself under the supervision of doctors. I request everyone who came in contact with me over the last few days to get themselves tested."

  • Mumbai local trains for general public may not start for next 3-4 weeks Nov 23, 2020 10:17 AM IST

    Mumbai local trains for general public may not start for next 3-4 weeks

    In a press conference, Municipal Commissioner Iqbal Singh Chahal said "The next 3 to 4 weeks will be very important for Mumbai. The situation will be reviewed after 3 to 4 weeks and only then a decision would be taken. However, no further restrictions will be imposed in the city".

  • Coronavirus update: COVID-19 caseload in India breaches 91-lakh mark Nov 23, 2020 10:13 AM IST

    Coronavirus update: COVID-19 caseload in India breaches 91-lakh mark

    The total coronavirus cases mounted to91,39,865 while the death toll climbed to1,33,738 with 511 new fatalities, the data updated at 8 am showed.

  • Coronavirus state-wise tally November 23: Gujarat's COVID-19 tally rises to 1.97 lakh Nov 23, 2020 09:56 AM IST

    Coronavirus state-wise tally November 23: Gujarat's COVID-19 tally rises to 1.97 lakh

    With more than 17.8 lakh COVID-19 cases, Maharashtra has reported the highest number of infections, followed by Karnataka (8.73 lakh) and Andhra Pradesh (8.62 lakh).

  • COVID-19 update: Uttar Pradesh to test all travellers from Delhi, restrict social gatherings Nov 23, 2020 09:44 AM IST

    COVID-19 update: Uttar Pradesh to test all travellers from Delhi, restrict social gatherings

    Uttar Pradesh is also planning to impose restrictions on the number of people allowed at weddings and other social gatherings amid sput in COVID-19 cases.

  • Oxford COVID-19 vaccine update | India may approve emergency use once AstraZeneca gets UK nod: VK Paul Nov 23, 2020 09:03 AM IST

    Oxford COVID-19 vaccine update | India may approve emergency use once AstraZeneca gets UK nod: VK Paul

    The Phase 3 clinical trials of Oxford-Astrazeneca COVID-19 vaccine should be over by January/February 2021, said Dr VK Paul chairman of the National Expert Group on Vaccine Administration for COVID-19

  • International flights on November 23: Here are flights operated by Air India under Vande Bharat Mission Nov 23, 2020 07:37 AM IST

    International flights on November 23: Here are flights operated by Air India under Vande Bharat Mission

    International flights: Check flights leaving for and from India to bring back stranded Indians.

  • India says local COVID-19 vaccine final trials could end within two months Nov 23, 2020 07:32 AM IST

    India says local COVID-19 vaccine final trials could end within two months

    The state-run Indian Council of Medical Research (ICMR) and privately-held Bharat Biotech this month started third-stage trials of COVAXIN, in a process that would involve 26,000 volunteers. It is the most advanced Indian experimental vaccine.

  • US vaccine program head says first Americans could be vaccinated on December 11: Report Nov 23, 2020 07:27 AM IST

    US vaccine program head says first Americans could be vaccinated on December 11: Report

    “Our plan is to be able to ship vaccines to the immunization sites within 24 hours from the approval, so I expect maybe on day two after approval on the 11th or the 12th of December,” he said.

Sections